Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $504,136 - $604,504
-8,200 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $609,451 - $713,893
-10,300 Reduced 55.68%
8,200 $485,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $5.96 Million - $6.7 Million
-100,400 Reduced 84.44%
18,500 $1.17 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $5.71 Million - $6.47 Million
98,900 Added 494.5%
118,900 $7.38 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.72 Million - $1.91 Million
-30,000 Reduced 60.0%
20,000 $1.21 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $1.51 Million - $1.76 Million
27,500 Added 122.22%
50,000 $2.94 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $348,000 - $505,725
-7,500 Reduced 25.0%
22,500 $1.25 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $1.36 Million - $1.5 Million
-30,500 Reduced 50.41%
30,000 $1.36 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $2.73 Million - $3.25 Million
60,500 New
60,500 $2.89 Million
Q2 2017

Jan 25, 2018

SELL
N/A
-11,900 Closed
0 $0
Q1 2017

Feb 26, 2018

BUY
N/A
11,781 Added 9900.0%
11,900 $647,000
Q1 2017

Jan 25, 2018

SELL
N/A
-11,781 Reduced 99.0%
119 $4,000
Q4 2016

Feb 23, 2018

BUY
N/A
11,781 Added 9900.0%
11,900 $695,000
Q4 2016

Jan 24, 2018

BUY
N/A
119
119 $28,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.